Not logged in.png)
Share.png)
SaveShare Save Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review
Ozmen, Deniz; Kurekci, Derya Deniz; Ozkocaman, Vildan; Avci, Burcu Altindag; Bozer, Denis Sabriye; Kasar, Mutlu; Sahin, Osman; Korkmaz, Gulten; Can, Ferda; Pepeler, Mehmet Sezgin; Erkut, Nergiz; Kirkizlar, Onur; Uygun, Kubra Yel; Bulduk, Tuba; Yildirim, Murat; Aslaner, Muzeyyen; Altindal, Sermin; Arikan, Fatma; Dal, Mehmet Sinan; Deveci, Burak; Guler, Nil; Kursad Gunes, Ahmet; Gurkan, Emel; Ozbalci, Demircan; Ozturk, Osman Can; Ulkuden, Burcu; Yilmaz, Huseyin; Yuksel, Meltem Kurt; Ayli, Meltem; Demir, Ahmet Muzaffer; Ozatlci, Duzgun; Ozkalemkas, Fahir; Saydam, Guray; Sonmez, Mehmet; Turgut, Burhan; Turgut, Mehmet; Unal, Ali; Eskazan, Ahmet Emre Share Save Clinical and Pathological Evaluation of CD5/SOX11 Status in Mantle Cell LymphomaPatir, Damla Cagla; Limoncu, Ozlem; Demir, Derya; Ozsan, Nazan; Hekimgil, Mine; Gunes, Ajda; Soyer, Nur; Sahin, Fahri; Vural, Filiz; Saydam, Guray; Tobu, Mahmut Share Save Share Save Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b studyPassamonti, Francesco; Paiandri, Francesca; Saydam, Guray; Callum, Jeannie; Devos, Timothy; Guglielmeffi, Paola; Vannucchi, Alessandro M.; Zor, Evren; Zuurman, Mike; Gilotti, Geralyn; Zhang, Yifan; Griesshammer, Martin Share Save PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia*Kayabasi, Cagla; Yelken, Besra Ozmen; Asik, Aycan; Okcanoglu, Tugce Balci; Sogutlu, Fatma; Gasimli, Roya; Susluer, Sunde Yilmaz; Saydam, Guray; Avci, Cigir Biray; Gunduz, Cumhur Share Save Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyAkay, Olga Meltem; Ozbalak, Murat; Pehlivan, Mustafa; Yildiz, Birol; Uzay, Ant; Yigenoglu, Tugce Nur; Elverdi, Tugrul; Kaynar, Leylagul; Ayyildiz, Orhan; Yonal Hindilerden, Ipek; Goksoy, Hasan Sami; Izmir Guner, Sebnem; Gunes, Ahmet Kursad; Sonmez, Mehmet; Kurt Yuksel, Meltem; Civriz Bozdag, Sinem; Ozkurt, Zubeyde Nur; Toptas, Tayfur; Dogu, Mehmet Hilmi; Salim, Ozan; Saydam, Guray; Yavasoglu, Irfan; Ayli, Meltem; Ozet, Gulsum; Albayrak, Murat; Birtas Atesoglu, Elif; Toprak, Selami K.; Yildirim, Rahsan; Mehtap, Ozgur; Kalayoglu Besisik, Sevgi; Nalcaci, Meliha; Altuntas, Fevzi; Ferhanoglu, Burhan Share Save Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experienceBekoz, Huseyin; Ozbalak, Murat; Karadurmus, Nuri; Paydas, Semra; Turker, Alev; Toptas, Tayfur; Tuglular, Tulin Firatli; Altuntas, Fevzi; Cakar, Merih Kizil; Sonmez, Mehmet; Gulbas, Zafer; Demir, Nazli; Kaynar, Leylagul; Yildirim, Rahsan; Karadogan, Ihsan; Arat, Mutlu; Kapucu, Irem; Aslan, Nevin Alayvaz; Ozkocaman, Vildan; Turgut, Mehmet; Yuksel, Meltem Kurt; Ozcan, Muhit; Hacioglu, Sibel Kabukcu; Barista, Ibrahim; Demirkaya, Metin; Saydam, Guray; Toprak, Selami K.; Yilmaz, Mehmet; Demirkol, Onur; Ferhanoglu, Burhan Share Save Share Save Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trialGriesshammer, Martin; Saydam, Guray; Palandri, Francesca; Benevolo, Giulia; Egyed, Miklos; Callum, Jeannie; Devos, Timothy; Sivgin, Serdar; Guglielmelli, Paola; Bensasson, Caroline; Khan, Mahmudul; Ronco, Julian Perez; Passamonti, Francesco Share Save Share Save Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studiesKiladjian, Jean-Jacques; Guglielmelli, Paola; Griesshammer, Martin; Saydam, Guray; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Jones, Mark; Zhen, Huiling; Li, Jingjin; Gadbaw, Brian; Ronco, Julian Perez; Khan, Mahmudul; Verstovsek, Srdan Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
